Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells
Authors:
- Ibrahim YounosIYIbrahim Younos
- Moses DonkorMDMoses Donkor
- Traci HokeTHTraci Hoke
- Alicia DaffernerADAlicia Dafferner
- Holly SamsonHSHolly Samson
- Sherry WestphalSWSherry Westphal
- James TalmadgeJTJames Talmadge
- 1 July 2011
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 11 (7) , 816-826
Abstract
No abstract availableKeywords
Funding Information
- Nebraska Research Initiative
This publication has 63 references indexed in Scilit:
- Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSFEuropean Journal of Immunology, 2009
- Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cellsInternational Immunopharmacology, 2009
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsProceedings of the National Academy of Sciences, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- Modulation of the antitumor immune response by complementNature Immunology, 2008
- Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasisNature Cell Biology, 2006
- Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancerCancer and Metastasis Reviews, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996